Full name
NEUROKLINIKA DA VINCI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.22.Z - Specialist medical practice
2022 | 2023 | ||
---|---|---|---|
K PLN | K PLN | % | |
Profit (loss) on sale | 9,9 | 12,6 | 28 |
Gross profit (loss) | 9,9 | 12,6 | 28 |
EBITDA | 30 | 32,1 | 7 |
Short time liabilities | 212,4 | 192,3 | -9,5 |
Other operating costs | 0 | 0 | 0 |
Equity capital | 14,5 | 25 | 72,2 |
Operating profit (EBIT) | 9,9 | 12,6 | 28 |
Assets | 226,9 | 217,3 | -4,2 |
Net profit (loss) | 9,9 | 10,5 | 6,3 |
Cash | 37,2 | 47 | 26,3 |
Net income from sale | 360,8 | 418,6 | 16 |
Liabilities and provisions for liabilities | 212,4 | 192,3 | -9,5 |
Working assets | 37,2 | 47 | 26,3 |
Other income costs | 0 | 0 | 0 |
Depreciation | 20,1 | 19,4 | -3,3 |
% | % | p.p. | |
Profitability of capital | 68 | 41,9 | -26,1 |
Equity capital to total assets | 6,4 | 11,5 | 5,1 |
Gross profit margin | 2,7 | 3 | 0,3 |
EBITDA Margin | 8,3 | 7,7 | -0,6 |
Days | Days | Days | |
Short term commitment turnover cycle | 215 | 168 | -47 |
Current financial liquidity indicator | 0.17525871098041534 | 0.24459485709667206 | 0 |
Net dept to EBITDA | -1.2415367364883423 | -1.4658551216125488 | -0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane